Paper34067321
Molecular and Cellular Mechanisms of Metformin in Cervical Cancer.
Chen YH and 4 others. Cancers (Basel), 2021. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Molecular and Cellular Mechanisms of Metformin in Cervical Cancer. Papers, record 34067321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34067321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25708557 | Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis. | Diabetes Metab Res Rev | 2015 | https://conductscience.org/library/papers/25708557 | PubMed |
| 2 | 17133272 | NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines. | Br J Cancer | 2006 | https://conductscience.org/library/papers/17133272 | PubMed |
| 3 | 27354763 | Molecular mechanisms of cisplatin resistance in cervical cancer. | Drug Des Devel Ther | 2016 | https://conductscience.org/library/papers/27354763 | PubMed |
| 4 | 28678319 | MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28678319 | PubMed |
| 5 | 28576465 | Metformin and caffeic acid regulate metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell cycle regulation. | Food Chem Toxicol | 2017 | https://conductscience.org/library/papers/28576465 | PubMed |
| 6 | 25455733 | Old drug, new trick: repurposing metformin for gynecologic cancers? | Gynecol Oncol | 2014 | https://conductscience.org/library/papers/25455733 | PubMed |
| 7 | 30720062 | Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling. | Int J Oncol | 2019 | https://conductscience.org/library/papers/30720062 | PubMed |
| 8 | 29337896 | Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29337896 | PubMed |
| 9 | 18566988 | Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. | Int J Cancer | 2008 | https://conductscience.org/library/papers/18566988 | PubMed |
| 10 | 23819460 | Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23819460 | PubMed |
| 11 | 23419783 | Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies. | Metabolism | 2013 | https://conductscience.org/library/papers/23419783 | PubMed |
| 12 | 33442295 | Liver Kinase B1 (LKB1) Regulates Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells via Targeting ERK Signaling Pathway. | Cancer Manag Res | 2021 | https://conductscience.org/library/papers/33442295 | PubMed |
| 13 | 24677093 | Role of AMP-activated protein kinase in cancer therapy. | Arch Pharm (Weinheim) | 2014 | https://conductscience.org/library/papers/24677093 | PubMed |
| 14 | 28617557 | Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28617557 | PubMed |
| 15 | 31009857 | The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses. | Eur J Obstet Gynecol Reprod Biol | 2019 | https://conductscience.org/library/papers/31009857 | PubMed |
| 16 | 31114366 | The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31114366 | PubMed |
| 17 | 32074084 | Metformin: current clinical applications in nondiabetic patients with cancer. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32074084 | PubMed |
| 18 | 29663879 | Anti-cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer. | Curr Drug Metab | 2018 | https://conductscience.org/library/papers/29663879 | PubMed |
| 19 | 29371974 | Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway. | Oncotarget | 2017 | https://conductscience.org/library/papers/29371974 | PubMed |
| 20 | 31864213 | iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/31864213 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42488672 | Mitochondrial reprogramming in cervical cancer: crosstalk with tumor immunity, HPV oncogenic signaling, and therapeutic resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488672 | PubMed |
| 41122720 | Synergistic impact of dysglycemia and HPV on cervical cancer risk: a potential mediating role of Ki-67. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41122720 | PubMed |
| 41018144 | Patterns of immune cell infiltration and oxidative stress in cervical cancer. | Oncol Rev | 2025 | https://conductscience.org/library/papers/41018144 | PubMed |
| 40792151 | Identification and validation of hub genes for kidney renal clear cell carcinoma treated with metformin and everolimus combination therapy. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40792151 | PubMed |
| 40522309 | Pleiotropic Effects of Metformin on the Chemotherapy Response of HPV-Positive Cancer Cells. | J Med Virol | 2025 | https://conductscience.org/library/papers/40522309 | PubMed |
| 40427115 | Real-World Data on the Associations of Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors with Gynecologic Cancer Risk. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40427115 | PubMed |
| 40337378 | Dissecting the role of metformin in urogenital malignancies. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40337378 | PubMed |
| 40098697 | lncRNA HIF1A-AS2 acts as an oncogene to regulate malignant phenotypes in cervical cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/40098697 | PubMed |
| 40001544 | Exploring the Effects of Metformin on the Body via the Urine Proteome. | Biomolecules | 2025 | https://conductscience.org/library/papers/40001544 | PubMed |
| 39844411 | Preventive and Therapeutic effects of Metformin in Cancer: A Meta- Analysis of RCT and Cohort Studies. | Curr Cancer Drug Targets | 2026 | https://conductscience.org/library/papers/39844411 | PubMed |
| 39595655 | Anti-Diabetic Therapies and Cancer: From Bench to Bedside. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595655 | PubMed |
| 39513110 | The lower incidence of cervical cancer in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors utilization. | J Cancer | 2024 | https://conductscience.org/library/papers/39513110 | PubMed |
| 39124936 | Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin. | Molecules | 2024 | https://conductscience.org/library/papers/39124936 | PubMed |
| 38664791 | Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana. | BMC Womens Health | 2024 | https://conductscience.org/library/papers/38664791 | PubMed |
| 37943796 | Pharmacophore mapping approach to find anti-cancer phytochemicals with metformin-like activities against transforming growth factor (TGF)-beta receptor I kinase: An in silico study. | PLoS One | 2023 | https://conductscience.org/library/papers/37943796 | PubMed |
| 37760509 | Antitumor Activity of Metformin Combined with Locoregional Therapy for Liver Cancer: Evidence and Future Directions. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760509 | PubMed |
| 36835224 | Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835224 | PubMed |
| 36551573 | Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36551573 | PubMed |
| 36387876 | Diabetes associated with cervical carcinoma among high-risk HPV-infected patients with cytologically diagnosed high grade squamous intraepithelial lesion. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36387876 | PubMed |
| 35222283 | Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35222283 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34067321
GET https://conductscience.org/api/papers/v1/34067321/references?page=2